Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha
about
Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patientsRespiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoterMutational analysis of the STAT6 SH2 domainInteraction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcriptionDivergent susceptibilities of human herpesvirus 6 variants to type I interferonsFunctional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signalingThe serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta primingTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseUrokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cellsStat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signalingCharacterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alphaType I interferon: friend or foe?Hypergeometric analysis of tiling-array and sequence data: detection and interpretation of peaks.PIPINO: A Software Package to Facilitate the Identification of Protein-Protein Interactions from Affinity Purification Mass Spectrometry DataResistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.CCM111, the water extract of Antrodia cinnamomea, regulates immune-related activity through STAT3 and NF-κB pathways.IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activationThe effect of IFNgamma on the hepatocyte: cell cycle and apoptosis.Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection.Differences in type I interferon signaling antagonism by dengue viruses in human and non-human primate cell lines.MicroRNAs and STAT interplay.A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosisMice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.Control of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production.Functional analysis of transcription factor binding sites in human promoters.Two Modes of the Axonal Interferon Response Limit Alphaherpesvirus NeuroinvasionType I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseasesConserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages.The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammationNuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9.Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferationSTAT signaling in mammary gland differentiation, cell survival and tumorigenesisType I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophagesOverexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7Model-based analysis of interferon-beta induced signaling pathway.
P2860
Q21144330-136913BD-B4EB-446E-BDD0-5E7E20EC6A6CQ24296927-DD7DB346-5557-4ABF-A1F9-D010C9722095Q24311539-2ECBB5C6-7D29-4118-A72A-D3613D3171EAQ24522496-0E69167A-C2F5-4ED3-A868-08AABB7E9E90Q24631220-36EB9900-7BD2-4062-9CFE-05F3614CAB24Q24646686-99D609E4-CCF8-449A-A583-4A8AE7A93B7BQ24647186-41E83FEC-7263-4FDC-9705-1EFFFEB9F784Q26750725-230B36A9-DE9F-45A1-9EB9-0883F604AEE5Q28142061-AC205CD7-2B99-4CC7-B443-951BB0FCDFB6Q28215240-831E9C18-96F1-4C52-8E66-80EC20E3129FQ28289207-5872578A-4E4A-409E-8C82-C3F1B90C888CQ28293186-681B1ABE-C559-4F0B-8E54-2EFE59F574EFQ30688439-56E9FFB9-E598-4CB4-9F5A-3F88F19D01F1Q31056803-28B55FEB-1EB2-4056-BE88-D8D1FF515BD6Q33598823-8BB9F356-439A-4523-8A7E-4107DA62A7E4Q33871711-886E47CD-BC1C-4846-9827-ECAEA3123A8BQ33884864-02442134-45E3-4DF8-B1C8-83FE8E025204Q34078171-8D25E7A7-DF06-4DF0-B21F-8A689E56DEDEQ34139499-1954A6C7-73D8-405C-9FE1-A979ED327A58Q34356962-F32D2571-8E6F-48A5-83DD-DEA85B910AD6Q34532591-504744F4-8401-4726-8109-AD791F28D526Q34773751-00882117-07D8-4850-8BC8-E0C91B25D97BQ35576590-A89F0C55-4808-49B4-9B05-6DF885DC5B03Q35785559-DB32A150-B59E-41A6-B9C4-9EBDDF8B6172Q35901899-AA6F8FE5-501C-42D0-9DFA-BD156C70849CQ36086689-4D1FB804-07C4-4185-90C0-D97CB8AB0638Q36145616-D7ACDEFB-333D-4E5B-91F7-E668C311B163Q36276591-27A1995B-FE85-4314-A70D-679C8E1EE87EQ36378033-B849379F-ABB0-42B6-85F3-EC2054F15001Q36548262-E4AC7CFA-F148-412A-8926-7153F746191FQ36569346-BA04BAF5-45FB-4C7F-B680-1C5660FE3573Q36588160-3D5C3FDC-887B-4517-8CE2-55C898C32C21Q36638466-99A004CA-7AA8-4319-A5AB-A2F849EC50CDQ36767466-D9D2D98C-BCE7-45BF-954B-C5ECF5DC158FQ36807357-3A548933-EEFE-40D6-87A0-114F4C29A5D4Q37052865-DF50B9E6-06A6-4C47-99BA-252C6E0DAFB9Q37107328-95D1D12C-1682-4696-BDC8-DD2E0BF86EFEQ37168039-9B78D97B-1760-4735-A91F-9DA4E4E97FFBQ37194209-F18C223F-AED5-4FD3-817D-B797F5D38E6CQ37288924-E26C3C9A-371C-4326-8A28-3C3944E303B9
P2860
Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@ast
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@en
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@nl
type
label
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@ast
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@en
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@nl
prefLabel
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@ast
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@en
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@nl
P2093
P2860
P3181
P356
P1476
Formation of STAT1-STAT2 heter ...... nscription by interferon-alpha
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.271.10.5790
P407
P577
1996-03-08T00:00:00Z